Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
27.22
+0.09 (0.33%)
At close: Oct 24, 2025, 4:00 PM EDT
27.25
+0.03 (0.11%)
After-hours: Oct 24, 2025, 5:23 PM EDT
Oruka Therapeutics Analyst Ratings
Total Analysts
7
Consensus Rating
Strong Buy
Price Target
$42.86
Upside
+57.46%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Initiates $48 | Buy | Initiates | $48 | +76.34% | Oct 13, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $56 | Strong Buy | Reiterates | $56 | +105.73% | Sep 29, 2025 |
| BTIG | BTIG | Strong Buy Maintains $44 → $56 | Strong Buy | Maintains | $44 → $56 | +105.73% | Sep 17, 2025 |
| Clear Street | Clear Street | Strong Buy Maintains $46 | Strong Buy | Maintains | $46 | +68.99% | Sep 17, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $45 | Strong Buy | Reiterates | $45 | +65.32% | Aug 18, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $45 | Strong Buy | Reiterates | $45 | +65.32% | Jul 23, 2025 |
| Wedbush | Wedbush | Buy Reiterates $40 | Buy | Reiterates | $40 | +46.95% | May 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $45 | Strong Buy | Reiterates | $45 | +65.32% | Feb 7, 2025 |
| Wolfe Research | Wolfe Research | Buy Initiates $20 | Buy | Initiates | $20 | -26.52% | Feb 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $45 | Strong Buy | Reiterates | $45 | +65.32% | Dec 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $45 | Strong Buy | Reiterates | $45 | +65.32% | Nov 25, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $45 | Strong Buy | Reiterates | $45 | +65.32% | Oct 31, 2024 |
| Stifel | Stifel | Strong Buy Initiates $49 | Strong Buy | Initiates | $49 | +80.01% | Oct 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +65.32% | Oct 7, 2024 |
| Leerink Partners | Leerink Partners | Buy Initiates $44 | Buy | Initiates | $44 | +61.65% | Sep 17, 2024 |
| Leerink Swann | Leerink Swann | Buy Initiates $44 | Buy | Initiates | $44 | +61.65% | Sep 17, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.